INSILICO MEDICINE
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases. It pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning, and meta-learning for the generation of novel molecular structures for the diseases with known and unknown targets, and, unlike the other companies in the field, is developing the end-to-end pipeline covering every step of drug discovery, clinical trials analysis, and digita... l medicine. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life Extension, the company launched a range of nutraceutical products, which were compounded using advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI.
INSILICO MEDICINE
Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Hong Kong, Hong Kong Island, Hong Kong
Country:
Hong Kong
Website Url:
http://www.insilico.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
401.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Euro COVID-19
Similar Organizations
3billion
3billion is a world leader in the field of genetic diagnostics for rare disease.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
B Capital Group
B Capital Group investment in Series D - Insilico Medicine
BHR Partners
BHR Partners investment in Series D - Insilico Medicine
Prosperity7 Ventures
Prosperity7 Ventures investment in Series D - Insilico Medicine
Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati investment in Series D - Insilico Medicine
Deerfield
Deerfield investment in Series D - Insilico Medicine
Pavilion Capital
Pavilion Capital investment in Series D - Insilico Medicine
Warburg Pincus
Warburg Pincus investment in Series D - Insilico Medicine
Qiming Venture Partners
Qiming Venture Partners investment in Series D - Insilico Medicine
Bold Capital Partners
Bold Capital Partners investment in Series D - Insilico Medicine
Bold Capital Partners
Bold Capital Partners investment in Series D - Insilico Medicine
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.insilico.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.88 K
- Host name: 185.215.4.66
- IP address: 185.215.4.66
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen